Skip to main content

Klebsiella pneumoniae: Antimicrobial Resistance, Virulence and Therapeutic Strategies

49kviews
Editorial23 December 2022
Editorial: Klebsiella pneumoniae: Antimicrobial resistance, virulence and therapeutic strategies

Pathogen Interaction, Molecular epidemiology, Genomic analysis Klebsiella pneumoniae is a member of the ESKAPE organisms which include 6 well-known highly virulent and antimicrobial-resistant clinical pathogens (Dong et al., 2022). K.pneumoniae has gained the ability to acquire external genetic materials that enable it to undergo constant evolution (Russo and Marr, 2019). The pathotypes reported to be associated with infections included classical (cKP) and hypervirulent K. pneumoniae (hvKP), with the former known for the capacity to acquire resistance to a wide range of antibiotics and the latter exhibiting high pathogenicity and leading to high mortality in otherwise immunocompromised hosts (Paczosa and Mecsas, 2016). To date, more than 100 distinct acquired antimicrobial resistance genes have been identified in K. pneumoniae (Wyres and Holt, 2016). Furthermore, apart from the well-established factors that help K. pneumoniae escape the innate immune mechanisms of the host, new virulence factors have been discovered (Walker et al., 2019;Walker et al., 2020;Gomes et al., 2021). Continuous effort is necessary to better understand this 'superbug' and help design feasible approaches to eradicate or halt its further evolution. As a step towards countering the threat of K. pneumoniae, our research topic brings a collection of seven selected articles exploring its molecular epidemiology, antimicrobial resistance, and pathogenesis. K. pneumoniae is a common pathogen of community-acquired pneumonia (CAP) in Asian countries (Song et al., 2008). Chen et al. revisited the burden of K. pneumoniae bacteremic pneumonia (KPBP) and determined the risk factors associated with 28-day mortality by analyzing data from 150 patients with KPBP in Taiwan from 2014-2020. A remarkably high 28-day mortality was observed in all patients. hvKP was more prevalent in CAP than in nosocomial pneumonia, yet carbapenem-resistant K. pneumoniae (CRKP) was more prevalent in nosocomial pneumonia than in CAP. Nosocomial pneumonia, Severe Organ Failure Assessment core, and lack of appropriate definitive treatment were positive predictors for 28day mortality among patients with KPBP. The results suggested host factors, disease severity, and timely effective therapy could affect the treatment outcomes of patients with KPBP.Information regarding hvKp infections in pediatric patients remains limited. Du et al. characterized K. pneumoniae strains from a children's hospital in Shanghai during 2019-2020.They found KPC-2-producing KL47-ST11 hypervirulence genes-positive (hgKp) increased dramatically from 5.3% in 2019 to 67.6% in 2020, suggesting genetic convergence of virulence and carbapenem-resistance in K. pneumoniae is increasing among children. hgKp could be classified into hvKP (32.5%) and hgKp-low virulence strains (67.5%). hvKp infections in children were mostly hospital-associated and commonly involved severe pneumonia. In hvKp, diverse genetic clones were observed and K1-ST23 and K2-ST25 were the dominant clones.These findings suggested the dramatic spread of hvKP in children. Gastrointestinal carriage is a major reservoir of K. pneumoniae infection (Gorrie et al., 2017). Migliorini et al. investigated the mechanisms associated with the transition from carriage to infection by K. pneumoniae isolates carrying blaKPC by characterizing KPC-producing strains isolated within a 10-year period. They showed the presence of resistance and virulence mechanisms were not associated with progression from colonization to infection, while intestinal colonization by carbapenem-resistant Enterobacteriaceae and, more specifically, the load of gastrointestinal carriage emerged as an important determinant of infection.ST11 is reported to be the dominant CRKP clone in China (Qi et al., 2011). TMexCD1-TOprJ1 is the first plasmid-borne RND-type tigecycline resistance determinant reported recently (Lv et al., 2020). Li et al. (2022b) The Klebsiella genus comprises a wide diversity of species apart from K. pneumoniae (Dong et al., 2022). Drug-resistant K. michiganensis strains have been increasingly reported recently. Li et al. (2022a) reported the first clinical multidrug-resistant K. michiganensis strain coharboring two blaSIM-1, one mcr-9.2, and 23 other resistance genes. They further comprehensively investigated the population structure and antibiotic-resistance genes of K. michiganensis by studying 275 publicly available genomes. Two major clades were identified, with the most popular sequence type ST29 being located in Clade 1, while other common STs (such as ST50, ST27, and ST43) in Clade 2. 25.5% K. michiganensis harbored at least one carbapenemase gene. ST27 isolates possess the most drug-resistance gene number among all the STs. The results of this study improved the understanding of K. michiganensis.Infection caused by cKP represents a significant challenge due to its rising antibiotic resistance. Mackel et al. dissected the adaptive immune responses elicited by live cKp infection and investigated how these responses protected the host from reinfection by using a lung inoculation plus challenge model. They found circulating antibody responses alone were not sufficient to mediate protection against cKP, yet either of the major T cell subsets alone (γδ or αβ) was sufficient to mediate protection; also, the circulating T cell pool was not required for the protective phenotype. These findings altogether demonstrated the imperative contribution of T cells to protective immunity against cKP which would guide further inquiries into host effector responses required to control cKP infection.The articles presented in this collection provide a valuable addition to the understanding of the notorious pathogen, K. pneumoniae. We hope these contributions will help investigators in their continuous scientific pursuit to tackle issues around the antimicrobial resistance and hypervirulence of this superbug. Related fields such as accurate and rapid pathogen detection and the design of optimal treatment regimens warrant further attention.

4,515 views

12 citations

ORIGINAL RESEARCH
29 August 2022
Nosocomial dissemination of hypervirulent Klebsiella pneumoniae with high-risk clones among children in Shanghai

4,813 views

27 citations

ORIGINAL RESEARCH
5 January 2023
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions
Dafne Bongiorno, 12 more and Stefania Stefani

4,186 views

24 citations

ORIGINAL RESEARCH
5 July 2022
The Gastrointestinal Load of Carbapenem-Resistant Enterobacteriacea Is Associated With the Transition From Colonization to Infection by Klebsiella pneumoniae Isolates Harboring the blaKPC Gene
Letícia Busato Migliorini, 9 more and Patricia Severino

4,311 views

20 citations

ORIGINAL RESEARCH
31 August 2022
Classical and γδ T cells are each independently sufficient to establish protection against a classical strain of Klebsiella pneumoniae
Joseph J. Mackel, 3 more and David A. Rosen

3,818 views

16 citations

ORIGINAL RESEARCH
24 August 2022
A blaSIM-1 and mcr-9.2 harboring Klebsiella michiganensis strain reported and genomic characteristics of Klebsiella michiganensis
Shuangshuang Li, 13 more and Fei Chen

3,814 views

10 citations

ORIGINAL RESEARCH
23 June 2022
Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
I-Ren Chen, 4 more and Yi-Tsung Lin
Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
Klebsiella pneumoniae is a common pathogen of nosocomial pneumonia worldwide and community-acquired pneumonia (CAP) in Asia. Previous studies have shown that K. pneumoniae bacteremic CAP is associated with high mortality. We aimed to revisit K. pneumoniae bacteremic pneumonia in the current era and determine the risk factors associated with 28-day mortality. Between January 2014 and August 2020, adult patients with K. pneumoniae bacteremic pneumonia in a medical center in Taiwan were identified. Clinical and microbiological characteristics were compared between CAP and nosocomial pneumonia. Risk factors for 28-day mortality were analyzed using multivariate logistic regression. Among 150 patients with K. pneumoniae bacteremic pneumonia, 52 had CAP and 98 had nosocomial pneumonia. The 28-day mortality was 52% for all patients, 36.5% for CAP, and 60.2% for nosocomial pneumonia. Hypervirulent K. pneumoniae was more prevalent in CAP (61.5%) than in nosocomial pneumonia (16.3%). Carbapenem-resistant K. pneumoniae was more prevalent in nosocomial pneumonia (58.2%) than in CAP (5.8%). Nosocomial pneumonia, a higher Severe Organ Failure Assessment score, and not receiving appropriate definitive therapy were independent risk factors for 28-day mortality. In conclusion, revisiting K. pneumoniae bacteremic pneumonia in the current era showed a high mortality rate. Host factors, disease severity, and timely effective therapy affect the treatment outcomes of these patients.

10,172 views

57 citations

ORIGINAL RESEARCH
12 May 2022
Emergence of Plasmids Co-Harboring Carbapenem Resistance Genes and tmexCD2-toprJ2 in Sequence Type 11 Carbapenem Resistant Klebsiella pneumoniae Strains
Xi Li, 7 more and Yuexing Tu

4,379 views

11 citations